) Endothelial cells in tumor vessels express angiogenic markers that are not detectable in normal vessels. We have developed an in vivo selection system in which phage capable of homing to tumors are recovered from a phage display peptide library following intravenous administration. Using this strategy, we have isolated several tumor-homing phage. Among those were phage displaying the tripeptides asparagine-glycine-arginine (NGR), glycine-serine-arginine (GSL), and a double cyclic RGD (RGD-4C). We have shown that each of those peptides binds to three different receptors that are upregulated in tumor angiogenic vasculature. Based on our in vivo studies targeting tumors with NGR-, GSL- and RGD-4C-phage, we will develop a peptide-based molecular adaptor for targeted delivery of genes to angiogenic vasculature. This goal will be achieved by screening phage peptide libraries on immobilized adenovirus and AAV. The libraries will be engineered so that phage display peptides that contain tumor-homing domains in addition to all possible permutations of a 10aa-long insert (i.e., CNGRC-X10, CGSLC-X10, and RGD-4C-X10). We will also study which of the three receptor systems is best suited for gene delivery using the adaptors. Receptor-mediated internalization and gene expression levels will be studied in vitro by confocal microscopy using endothelial cells expressing the receptors. We plan to evaluate the efficiency of gene expression and angiogenesis inhibition upon targeted delivery of three classes of genes to angiogenic vasculature: (i) suicide; (ii) pro-apoptotic; and (iii) genes encoding angiogenesis inhibitors such as endostatin and angiostatin. Transgenic models of pancreatic carcinoma (Rip-Tag) and prostate carcinoma (TRAMP) will be used. Finally, we will examine the therapeutic effects of targeted delivery of suicide and pro-apoptotic genes to angiogenic vasculature using an animal model of oxygen-induced retinal angiogenesis. These studies may lead to development of new gene therapy-based tumor treatment strategies that rely on inhibition of angiogenesis. Vector targeting would represent a major advance in cancer treatment. Given that our peptides also target angiogenic vasculature in the retina, these advances are also likely to extend the potential for neovasculature-specific gene therapy targeting to other diseases involving angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA088106-01
Application #
2904338
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (M1))
Program Officer
Wolpert, Mary K
Project Start
2000-01-10
Project End
2004-11-30
Budget Start
2000-01-10
Budget End
2000-11-30
Support Year
1
Fiscal Year
2000
Total Cost
$162,336
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Dentistry
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Yuan, Z; Syrkin, G; Adem, A et al. (2013) Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-? leads to synergistic antitumor activity. Cancer Gene Ther 20:46-56
Sergeeva, Anna; Kolonin, Mikhail G; Molldrem, Jeffrey J et al. (2006) Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 58:1622-54
Yao, Virginia J; Ozawa, Michael G; Varner, Amanda S et al. (2006) Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels. Cancer Res 66:2639-49
Yao, Virginia J; Ozawa, Michael G; Trepel, Martin et al. (2005) Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. Am J Pathol 166:625-36
Kolonin, Mikhail G; Saha, Pradip K; Chan, Lawrence et al. (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625-32
Arap, Marco A; Lahdenranta, Johanna; Hajitou, Amin et al. (2004) Model of unidirectional transluminal gene transfer. Mol Ther 9:305-10
Marchio, Serena; Lahdenranta, Johanna; Schlingemann, Reinier O et al. (2004) Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5:151-62
Chen, Limor; Zurita, Amado J; Ardelt, Peter U et al. (2004) Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol 11:1081-91
Arap, Marco A; Lahdenranta, Johanna; Mintz, Paul J et al. (2004) Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 6:275-84
Trepel, M; Grifman, M; Weitzman, M D et al. (2000) Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum Gene Ther 11:1971-81